Rare Oslo bio IPO blows out on day one
The Oslo Stock Exchange is set to host a rare biotech IPO. Nordic Nanovector, a Norwegian company that is developing antibody-radio conjugates, is seeking to raise Nkr400m ($50m) of new capital.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts